2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Cardiotoxicity
14
Breast Neoplasms
11
Lymphoma, Non-Hodgkin
5
Neoplasms
4
Lymphoma
4
Heart Failure
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Leukemia
2
Heart Diseases
2
Cardiovascular Diseases
2
Burkitt Lymphoma
2
Ventricular Dysfunction, Left
1
Ventricular Dysfunction
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Peritoneal Neoplasms
1
Obesity
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Metastatic Solid Tumors
1
Metabolic Syndrome
1
Mesothelioma
1
Memory Disorders
1
Interventions
Blood Specimen Collection
3
Exercise
2
evolocumab
1
Ultrasonography, Carotid Arteries
1
Standard of Care
1
Rosuvastatin Calcium
1
Positron Emission Tomography Computed Tomography
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
Human Growth Hormone
1
Growth Hormone
1
Echocardiography
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Atherosclerosis
×
Echocardiography
×
Clear all
NCT06597045
2024-09-19
BIOCAPRI
NHS Greater Glasgow and Clyde
Active not recruiting
60 enrolled